| Date | Title | | | 09/20/06 | Genoptix, Inc. to Present at 2006 UBS Global Life Sciences Conference| SAN DIEGO, September 20, 2006 - Genoptix, Inc., today announced that it is presenting at the 2006 UBS Global Life Sciences Conference, Tuesday, September 26th at 11:00am EDT. Tina Nova, Ph.D., Genoptix President and CEO, and Sam Riccitelli, EVP and COO, will address the conference, which runs September 25-28, 2006 at the Grand Hyatt, New York.
The audio-only live webcast will be accessible through the UBS website at www.ibb.ubs.com or through the Genoptix website at www.genoptix.com. A replay... |
|  | | 07/10/06 | Genoptix Announces FDA Cleared Test to Identify Circulating Tumor Cells:|
Test helps physicians and patients fight metastatic breast cancer soonerSAN DIEGO, July 10, 2006 - Genoptix, Inc., a provider of personalized medicine oncology services, today announced it will be one of two national laboratories to offer the CellSearch™ System, the only FDA cleared test that identifies circulating tumor cells (CTCs) in patients with metastatic breast cancer.
"CellSearch is an important diagnostic tool designed to help oncologists and their patients fight cancer," said Dr. ... |
| | | 06/27/06 | Genoptix Announces Collaboration with Biogen Idec | San Diego, CA, June 27, 2006 - Genoptix, Inc., a CLIA and CAP certified clinical laboratory, today announced it will provide expertise in flow cytometry testing to Biogen Idec and will collaborate with the company in assay development to support upcoming clinical trials.
Genoptix is well known for its focus on providing high quality and personalized clinical esoteric services to hematologists/oncologists, which aid in the evaluation and management of hematomalignancies. In addition, Genoptix ... |
| |
|
